drugset / Trial / NCT04855266

Iron Sucrose in Patients With Iron Deficiency and POTS

NCT04855266

Phase 2 Withdrawn Mayo Clinic
RandomizedParallel-groupDouble-blindTreatment

Summary

This study aims to investigate whether the treatment of non-anemic iron deficiency with intravenous iron sucrose will result in decreased symptom reporting and improved cardiovascular indices in patients with Postural Orthostatic Tachycardia syndrome (POTS).

Timeline

Start
2021-04
Primary completion
2023-05
Completion
2023-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Iron sucrose Unknown 5 mg/kg Intravenous